Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OptiNose Inc (OPTN)

  • Technical Exchange News
  • Jan. 17, 2025, 03:04 UTC
  • 25

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Jan. 17, 2025, 03:04 UTC
  • 25

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Precigen Inc (PGEN)

  • Technical Exchange News
  • Jan. 16, 2025, 18:39 UTC
  • 24

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

OptiNose Inc (OPTN)

  • Technical Exchange News
  • Jan. 16, 2025, 18:39 UTC
  • 25

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Jan. 16, 2025, 18:38 UTC
  • 26

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocean Biomedical Inc (OCEA)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 22

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Mainz Biomed (MYNZ)

  • Technical Exchange News
  • Jan. 16, 2025, 02:58 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • Jan. 15, 2025, 19:08 UTC
  • 20

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ocean Biomedical Inc (OCEA)

  • Technical Exchange News
  • Jan. 15, 2025, 19:07 UTC
  • 25

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text
  • Previous
  • 125
  • 126
  • 127
  • 128
  • 129
  • Next

Search

News categories

  • Technical Exchange News(9391)
  • Event(407)
  • SEC News(153820)
  • FDA Approval(8775)
  • Company Report(721)
  • Business News(104835)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin